BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jeyarajan AJ, Chung RT. Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure? J Infect Dis 2020;222:S802-13. [PMID: 33245355 DOI: 10.1093/infdis/jiaa279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Pécheur EI. Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a 'miR'-velous opportunity of early diagnosis? AIDS 2021;35:1499-500. [PMID: 34185715 DOI: 10.1097/QAD.0000000000002921] [Reference Citation Analysis]
2 Cheng Z, Lin P, Cheng N. HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases. Front Med (Lausanne) 2021;8:713981. [PMID: 34676223 DOI: 10.3389/fmed.2021.713981] [Reference Citation Analysis]
3 Gobran ST, Ancuta P, Shoukry NH. A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection. Front Immunol 2021;12:726419. [PMID: 34456931 DOI: 10.3389/fimmu.2021.726419] [Reference Citation Analysis]
4 Benedicto AM, Fuster-Martínez I, Tosca J, Esplugues JV, Blas-García A, Apostolova N. NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved. Cells 2021;10:1687. [PMID: 34359857 DOI: 10.3390/cells10071687] [Reference Citation Analysis]
5 He J, Liu X, Duan S, Ye R, Yang Y, Wang J, He N. Untargeted plasma metabolomics reveals extensive metabolic alterations among treatment naïve HIV/HCV co-infected patients with liver disease progression. AIDS Res Hum Retroviruses 2022. [PMID: 35383478 DOI: 10.1089/AID.2021.0123] [Reference Citation Analysis]
6 Kouroumalis E, Voumvouraki A. Hepatitis C virus: A critical approach to who really needs treatment. World J Hepatol 2022; 14(1): 1-44 [DOI: 10.4254/wjh.v14.i1.1] [Reference Citation Analysis]